Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2014, Vol. 15 Issue (5): 412-428    DOI: 10.1631/jzus.B1400077
Reviews     
Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins
Rong-gang Ma, Yang Zhang, Ting-ting Sun, Bo Cheng
School of Life Sciences, Lanzhou University, Lanzhou 730000, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Polycomb group (PcG) complexes are epigenetic regulatory complexes that conduct transcriptional repression of target genes via modifying the chromatin. The two best characterized forms of PcG complexes, polycomb repressive complexes 1 and 2 (PRC1 and PRC2), are required for maintaining the stemness of embryonic stem cells and many types of adult stem cells. The spectra of target genes for PRCs are dynamically changing with cell differentiation, which is essential for proper decisions on cell fate during developmental processes. Chromobox (CBX) family proteins are canonical components in PRC1, responsible for targeting PRC1 to the chromatin. Recent studies highlight the function specifications among CBX family members in undifferentiated and differentiated stem cells, which reveal the interplay between compositional diversity and functional specificity of PRC1. In this review, we summarize the current knowledge about targeting and functional mechanisms of PRCs, emphasizing the recent breakthroughs related to CBX proteins under a number of physiological and pathological conditions.

Key wordsPolycomb      Polycomb repressive complex 1 (PRC1)      Chromobox (CBX) protein      Epigenetic regulation      Cancer     
Received: 16 March 2014      Published: 05 May 2014
CLC:  Q291  
  Q38  
Cite this article:

Rong-gang Ma, Yang Zhang, Ting-ting Sun, Bo Cheng. Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(5): 412-428.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1400077     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2014/V15/I5/412

[1] Meng-wen Zhang, Kenji Fujiwara, Xu Che, Shu Zheng, Lei Zheng. DNA methylation in the tumor microenvironment[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(5): 365-372.
[2] Xiao-chun Mao, Wen-qiao Yu, Jin-biao Shang, Ke-jing Wang. Clinical characteristics and treatment of thyroid cancer in children and adolescents: a retrospective analysis of 83 patients[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(5): 430-436.
[3] Shi-chong Liao, Jin-xin Li, Li Yu, Sheng-rong Sun. Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(4): 334-342.
[4] Shu-min Liu, Shi-yi Ou, Hui-hua Huang. Green tea polyphenols induce cell death in breast cancer MCF-7 cells through induction of cell cycle arrest and mitochondrial-mediated apoptosis[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(2): 89-98.
[5] Bo-yu Dong, Cheng Wang, Li Tan, Ning Tan, Meng-di Zhao, Yang Lu, Shou-ying Du. Inhibitory effect of Shenqi Fuzheng injection combined with docetaxel on lung cancer cells[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(1): 76-78.
[6] Ming Zhao, Xian-feng Ding, Jian-yu Shen, Xi-ping Zhang, Xiao-wen Ding, Bin Xu. Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(1): 15-26.
[7] Chun-xi Wang, Shu-li Guo, Li-na Han. Successful treatment of accessory breast cancer with endocrine therapy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(1): 70-75.
[8] Jian-zhen Shan, Yan-yan Xuan, Qi Zhang, Jian-jin Huang. Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(9): 672-682.
[9] Qiu-ping Xie, Cheng Xiang, Gang Wang, Ke-feng Lei, Yong Wang. MACC1 upregulation promotes gastric cancer tumor cell metastasis and predicts a poor prognosis[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(5): 361-366.
[10] Ri-sheng Que, Cheng Lin, Guo-ping Ding, Zheng-rong Wu, Li-ping Cao. Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(5): 352-360.
[11] Zeng-hui Cheng, Yu-xin Shi, Min Yuan, Dan Xiong, Jiang-hua Zheng, Zhi-yong Zhang. Chemokines and their receptors in lung cancer progression and metastasis[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(5): 342-351.
[12] Xiang Zhang, Yong-liang Gao, Yue Yang. Treatment and prognosis of cervical cancer associated with pregnancy: analysis of 20 cases from a Chinese tumor institution[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(5): 388-394.
[13] Zong-mao Chen, Zhi Lin. Tea and human health: biomedical functions of tea active components and current issues[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(2): 87-102.
[14] Zong-lin Li, Huai-wu Jiang, Min Song, Liang Xu, Dong Xia, Qing Liu. Secondary sentinel lymph node tracing technique: a new method for tracing lymph nodes in radical gastrectomy for advanced gastric cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(11): 897-903.
[15] Hui-xin Liu, Xiao-li Li, Chen-fang Dong. Epigenetic and metabolic regulation of breast cancer stem cells[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(1): 10-17.